Clinical Trials Directory

Trials / Conditions / Squamous Cell Carcinoma of the Lung

Squamous Cell Carcinoma of the Lung

7 registered clinical trials studyying Squamous Cell Carcinoma of the Lung — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced
NCT07217171
EvolveImmune United, IncPhase 1
Active Not RecruitingBOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
NCT05120271
Sotio Biotech Inc.Phase 1 / Phase 2
RecruitingStudy of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven
NCT04429542
Bicara TherapeuticsPhase 1
UnknownEvaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma
NCT03938012
National University Hospital, Singapore—
TerminatedStudy of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung
NCT02713828
PrECOG, LLC.Phase 1 / Phase 2
UnknownMetronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma
NCT01947062
Swami Rama Cancer Hospital and Research InstitutePhase 3
UnknownProof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours
NCT01795768
Royal Marsden NHS Foundation TrustPhase 2